CRESCO YELTRAH RECEIVES FIRST PERMISSION TO GROW IN THE PENNSYLVANIA MEDICAL MARIJUANA PROGRAMhttps://www.crescolabs.com/wp-content/uploads/2016/09/products-at-cresco-labs-25-1024x683.jpg 1024 683 admin admin https://secure.gravatar.com/avatar/018ce1536159deab276cd049fdbfd382?s=96&d=mm&r=g
(Pittsburgh, PA) Governor Tom Wolf announced today that Cresco Yeltrah is the first cultivator to have the state’s permission to begin growing and processing marijuana as part of the Pennsylvania Medical Marijuana program. Cresco Yeltrah, who was one of the highest scoring contenders in the state’s rigorous application process, is constructing a state-of-the-art cultivation center and laboratory in northwest Brookville and dispensaries in Butler, Pittsburgh (Strip District), and a third location soon to be announced.
“Providing relief to patients across the state as quickly as possible is our focus,” said Charlie Bachtell, Cresco Yeltrah co-founder. “We’re appreciative of the support the Governor and his administration have given this program – always keeping their focus on the best interests of patients. We’re very pleased to be the first company in Pennsylvania to produce medical marijuana,” he added.
Cresco Yeltrah began construction on converting the 40,000+ square foot facility nearly immediately after receiving their permit. While the overall facility will be constructed and equipped in phases, the state has signed off on the company’s secure growing environment being fully operational so the cultivation process can begin. All of the required mechanisms are in place to ensure the safety and security as required by law. With a controlled cultivation environment, a full grow cycle takes approximately 120 days which will allow for their complete line of products to be available for patients statewide in February 2018.
Cresco Yeltrah will grow a variety of over 30 different genetic strains in Brookville and will produce a unique array of innovative pharmaceutical-grade marijuana products ranging from high CBD strains, vapor oils, transdermal patches and pills. Cresco Yeltrahs distinctive line of products ensures patients will receive consistent, repeatable, precision-dosed medicine – as the program does not allow for the sale of raw marijuana flower. Their scientifically developed products utilize all beneficial properties of the marijuana plant including methods of relief without the typical “high” or euphoric feeling the plant is known for.
Cresco Yeltrah recently launched an awareness and outreach campaign, geared towards educating people who have been diagnosed with any of the approved 17 conditions. The campaign features billboards as well as print and digital ads that direct people to a comprehensive website as a resource for educating patients and doctors on the basics of medical marijuana, consumption methods, available forms and how to obtain a card.
- Posted In:
- Company News